These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27398163)

  • 1. Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesis.
    Tu Y; Wang Z; Wang X; Yang H; Zhang P; Johnson M; Liu N; Liu H; Jin W; Zhang Y; Cui D
    Am J Transl Res; 2016; 8(6):2803-11. PubMed ID: 27398163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate-induced growth inhibition in pancreatic cancer cells.
    Ikejiri F; Honma Y; Kasukabe T; Urano T; Suzumiya J
    Oncol Lett; 2018 Mar; 15(3):3240-3244. PubMed ID: 29435064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma and glioblastoma stem cells are dependent on functional MTH1.
    Pudelko L; Rouhi P; Sanjiv K; Gad H; Kalderén C; Höglund A; Squatrito M; Schuhmacher AJ; Edwards S; Hägerstrand D; Berglund UW; Helleday T; Bräutigam L
    Oncotarget; 2017 Oct; 8(49):84671-84684. PubMed ID: 29156675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MutT Homolog1 has multifaceted role in glioma and is under the apparent orchestration by Hypoxia Inducible factor1 alpha.
    Bhavya B; Easwer HV; Vilanilam GC; Anand CR; Sreelakshmi K; Urulangodi M; Rajalakshmi P; Neena I; Padmakrishnan CJ; Menon GR; Krishnakumar K; Deepti AN; Gopala S
    Life Sci; 2021 Jan; 264():118673. PubMed ID: 33130078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Double-Edged Sword: The Anti-Cancer Effects of Emodin by Inhibiting the Redox-Protective Protein MTH1 and Augmenting ROS in NSCLC.
    Wahi D; Soni D; Grover A
    J Cancer; 2021; 12(3):652-681. PubMed ID: 33403025
    [No Abstract]   [Full Text] [Related]  

  • 6. MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good?
    Abbas HHK; Alhamoudi KMH; Evans MD; Jones GDD; Foster SS
    BMC Cancer; 2018 Apr; 18(1):423. PubMed ID: 29661172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of MTH1 inhibition-induced DNA strand breaks: The slippery slope from the oxidized nucleotide pool to genotoxic damage.
    Rai P; Sobol RW
    DNA Repair (Amst); 2019 May; 77():18-26. PubMed ID: 30852368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting human MutT homolog 1 (MTH1) for cancer eradication: current progress and perspectives.
    Yin Y; Chen F
    Acta Pharm Sin B; 2020 Dec; 10(12):2259-2271. PubMed ID: 33354500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of MutT homolog 1 in distinct subtypes of breast cancer.
    Zhang X; Song W; Zhou Y; Mao F; Lin Y; Guan J; Sun Q
    Oncol Lett; 2017 Apr; 13(4):2161-2168. PubMed ID: 28454376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MTH1 in oxidative stress and therapeutic targeting of cancer.
    Taiyab A; Ashraf A; Sulaimani MN; Rathi A; Shamsi A; Hassan MI
    Redox Biol; 2024 Nov; 77():103394. PubMed ID: 39418911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and development of MTH1 inhibitors for treatment of cancer.
    Warpman Berglund U; Sanjiv K; Gad H; Kalderén C; Koolmeister T; Pham T; Gokturk C; Jafari R; Maddalo G; Seashore-Ludlow B; Chernobrovkin A; Manoilov A; Pateras IS; Rasti A; Jemth AS; Almlöf I; Loseva O; Visnes T; Einarsdottir BO; Gaugaz FZ; Saleh A; Platzack B; Wallner OA; Vallin KS; Henriksson M; Wakchaure P; Borhade S; Herr P; Kallberg Y; Baranczewski P; Homan EJ; Wiita E; Nagpal V; Meijer T; Schipper N; Rudd SG; Bräutigam L; Lindqvist A; Filppula A; Lee TC; Artursson P; Nilsson JA; Gorgoulis VG; Lehtiö J; Zubarev RA; Scobie M; Helleday T
    Ann Oncol; 2016 Dec; 27(12):2275-2283. PubMed ID: 27827301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer.
    Taiyab A; Choudhury A; Haidar S; Yousuf M; Rathi A; Koul P; Chakrabarty A; Islam A; Shamsi A; Hassan MI
    Biomed Pharmacother; 2024 Apr; 173():116332. PubMed ID: 38430630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.
    Magkouta SF; Pappas AG; Vaitsi PC; Agioutantis PC; Pateras IS; Moschos CA; Iliopoulou MP; Kosti CN; Loutrari HV; Gorgoulis VG; Kalomenidis IT
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32554927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588.
    Wang JY; Jin L; Yan XG; Sherwin S; Farrelly M; Zhang YY; Liu F; Wang CY; Guo ST; Yari H; La T; McFarlane J; Lei FX; Tabatabaee H; Chen JZ; Croft A; Jiang CC; Zhang XD
    J Invest Dermatol; 2016 Nov; 136(11):2277-2286. PubMed ID: 27427486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species.
    Qing X; Shao Z; Lv X; Pu F; Gao F; Liu L; Shi D
    Anticancer Drugs; 2018 Apr; 29(4):341-352. PubMed ID: 29420337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karonudib is a promising anticancer therapy in hepatocellular carcinoma.
    Hua X; Sanjiv K; Gad H; Pham T; Gokturk C; Rasti A; Zhao Z; He K; Feng M; Zang Y; Zhang J; Xia Q; Helleday T; Warpman Berglund U
    Ther Adv Med Oncol; 2019; 11():1758835919866960. PubMed ID: 31489034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of micronucleus induction in MTH1 knockdown cells exposed to UVA, UVB or UVC.
    Fotouhi A; Cornella N; Ramezani M; Wojcik A; Haghdoost S
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():161-5. PubMed ID: 26520386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer.
    Fujishita T; Okamoto T; Akamine T; Takamori S; Takada K; Katsura M; Toyokawa G; Shoji F; Shimokawa M; Oda Y; Nakabeppu Y; Maehara Y
    Lung Cancer; 2017 Jul; 109():52-57. PubMed ID: 28577950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the nucleic acid oxidative damage repair enzyme MTH1: a promising therapeutic option.
    Ding Y; Liu Q
    Front Cell Dev Biol; 2024; 12():1334417. PubMed ID: 38357002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.